Trailing-twelve-month (TTM) revenue is $25.18 Billion with a year-over-year growth of +2.35%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $6,517,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-21 |
| Q4 FY2025Period ended 2025-12-31 | $6,133,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-03 |
| Q1 FY2026Period ended 2026-03-31 | $6,030,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-21 |
| Q2 FY2026Period ended 2026-06-30 | $6,500,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-21 |
| TTM revenue | $25,180,000,000 |
Current P/S: $84,789,922,579 market capitalization ÷ $25,180,000,000 TTM revenue = 3.37x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T19:59:59.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $6.50B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T19:59:59.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Consumer Segment | $5.3B | $5.9B | $5.3B | $5.0B | $4.9B | $4.9B |
| Corporate Non Segment | N/A | $2M | $4M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Americas | $16.5B | $18.1B | $18.4B | $18.4B | $13.4B | $13.6B |
| Asia Pacific | $9.6B | $10.6B | $9.9B | $8.5B |
$25.18B
$25.18 Billion
+2.35%
vs. $24.60B a year ago (TTM)
(6.23%)
5 Year compound annual growth rate
1 Year
+2.35%
3 Year
(6.71%)
5 Year
(6.23%)
10 Year
(1.76%)
15 Year
(0.84%)
20 Year
+0.68%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $24.95B | +$373.00M | +1.52% |
| 2024 | $24.57B | ($35.00M) | (0.14%) |
| 2023 | $24.61B | ($9.62B) | (28.10%) |
| 2022 | $34.23B | ($1.13B) | (3.18%) |
| 2021 | $35.35B | +$3.17B | +9.85% |
| 2020 |
TTM Growth
+2.35%
3-Year CAGR
(6.71%)
5-Year CAGR
(6.23%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T19:59:59.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| Health Care Segment | $8.3B | $9.1B | $8.4B | $8.2B | N/A | N/A |
|---|
| Intersegment Elimination | -$2.1B | -$2.2B | N/A | N/A | N/A | N/A |
|---|
| Safety And Industrial Segment | $11.8B | $12.9B | $11.6B | $11.0B | $11.0B | $11.4B |
|---|
| Segment Reporting, Reconciling Item, Corporate Nonsegment | N/A | N/A | N/A | N/A | $271M | $372M |
|---|
| Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment | N/A | N/A | N/A | N/A | $32M | N/A |
|---|
| Transportation And Electronics Segment | $8.8B | $9.8B | $8.9B | $8.5B | $8.4B | $8.3B |
|---|
| $7.1B |
| E M E A | $6.1B | $6.7B | $5.9B | $5.8B | $4.2B | $4.3B |
|---|
| Other Unallocated Geographical | -$19M | -$2M | N/A | N/A | N/A | N/A |
|---|
| $32.18B |
| +$48.00M |
| +0.15% |
| 2019 | $32.14B | ($629.00M) | (1.92%) |
| 2018 | $32.77B | +$1.11B | +3.50% |
| 2017 | $31.66B | +$1.55B | +5.14% |
| 2016 | $30.11B | ($165.00M) | (0.55%) |
